May 10, 2023 5:30pm EDT Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debentures
May 09, 2023 6:21pm EDT Medexus Demonstrates Cost-Effectiveness of Gleolan-Guided Surgery for High-Grade Glioma
Apr 18, 2023 5:30pm EDT Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
Apr 11, 2023 7:25am EDT Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
Feb 08, 2023 5:00pm EST Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
